Related Experiment Video
Updated: Jun 4, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Pancreatic and hepatobiliary cancers.
Andreas K Buck1, Ken Herrmann, Florian Eckel
1Nuklearmedizinische Klinik und Poliklinik, Technische Universität München, München, Germany. andreas.buck@tum.de
Methods in Molecular Biology (Clifton, N.J.)
|February 19, 2011
Summary
Positron emission tomography (PET) with F-18 FDG enhances detection and staging of liver and pancreatic cancers. Hybrid PET-CT imaging integrates metabolic and morphologic data, improving diagnostic accuracy for these malignancies.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Conventional nuclear medicine modalities are being superseded by morphology-based imaging for detecting liver and pancreatic lesions.
- Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) offers a sensitive and specific method for identifying hepatic metastases and extrahepatic tumor deposits in hepatocellular and pancreatic cancers.
Purpose of the Study:
- To highlight the role of advanced imaging techniques, particularly PET-CT, in the diagnosis and management of hepatobiliary and pancreatic cancers.
- To discuss the application of specific radiopharmaceuticals for targeted tumor detection.
Main Methods:
- Utilizing F-18 FDG PET for sensitive detection of hepatic metastases and extrahepatic tumor deposits.
- Employing radiopharmaceuticals like Ga-68 DOTATOC and F-18 DOPA for specific detection of neuroendocrine pancreatic tumors.
- Integrating morphologic and metabolic information using hybrid PET-CT scanners.
Main Results:
- F-18 FDG PET improves the accuracy of staging primary liver and pancreatic tumors and aids in response monitoring.
- Hybrid PET-CT scanners enhance the sensitivity and specificity of noninvasive imaging across various tumor types.
- Innovations like SPECT-CT and specific radiopharmaceuticals increase the reliability of scintigraphic imaging.
Conclusions:
- PET-CT is a valuable tool for improving the accuracy of staging and response monitoring in hepatobiliary and pancreatic cancers.
- Advanced nuclear medicine techniques, including PET-CT and novel radiopharmaceuticals, significantly enhance the diagnostic capabilities for these malignancies.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:25Acute Pancreatitis I: Introduction
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: